Researchers at Kumamoto University have successfully executed a practical trial of a new genome-editing technique that allows ...

Explore the Genome Editing Market size, share, trends, and future growth. Learn about CRISPR, TALENs, ZFNs, and advancements shaping genetic research & medicine.

Shortly after this publication, Bogdanove struck up a collaboration with Daniel Voytas, a plant geneticist at the University ...

Researchers at Duke University and North Carolina State University have discovered a handful of new CRISPR-Cas systems that ...

US biotechnology company Colossal Laboratories and Biosciences has a radical proposal: it wants to resurrect the woolly ...

The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...

The growing occurrence of genetic disorders like sickle cell anemia, cystic fibrosis, and muscular dystrophy is fueling the demand for gene therapy and genome editing solutions, as these approaches ...

Genomics technologies, while powerful, are not sufficient to bring precision medicine into routine clinical practice.

Beam Therapeutics announced positive initial data for BEAM-302 in the Phase I/II trial in Alpha-1 Antitrypsin Deficiency (AATD).

The International Symposium on “Harnessing Genome Editing for Resilient Agriculture” concluded at the Gurdev Singh Khush ...

CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 ---- Advancing four clinical programs for ...